DK405286A - Anvendelse af dobbeltstrenget rna til behandling af aids - Google Patents

Anvendelse af dobbeltstrenget rna til behandling af aids Download PDF

Info

Publication number
DK405286A
DK405286A DK405286A DK405286A DK405286A DK 405286 A DK405286 A DK 405286A DK 405286 A DK405286 A DK 405286A DK 405286 A DK405286 A DK 405286A DK 405286 A DK405286 A DK 405286A
Authority
DK
Denmark
Prior art keywords
rna
aids
double
strength
treatment
Prior art date
Application number
DK405286A
Other languages
English (en)
Other versions
DK405286D0 (da
DK170139B1 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK405286D0 publication Critical patent/DK405286D0/da
Publication of DK405286A publication Critical patent/DK405286A/da
Application granted granted Critical
Publication of DK170139B1 publication Critical patent/DK170139B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
DK405286A 1985-08-26 1986-08-26 Anvendelse af dobbeltstrenget RNA til fremstilling af et middel til behandling af AIDS, fremgangsmåde til at gøre legemsvæsker eller blodlegemer resistente mod virusinfektion samt fremgangsmåde til fjernelse af vira DK170139B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76949485A 1985-08-26 1985-08-26
US76949485 1985-08-26
US88636386A 1986-07-17 1986-07-17
US88636386 1986-07-17

Publications (3)

Publication Number Publication Date
DK405286D0 DK405286D0 (da) 1986-08-26
DK405286A true DK405286A (da) 1987-02-27
DK170139B1 DK170139B1 (da) 1995-06-06

Family

ID=27118178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK405286A DK170139B1 (da) 1985-08-26 1986-08-26 Anvendelse af dobbeltstrenget RNA til fremstilling af et middel til behandling af AIDS, fremgangsmåde til at gøre legemsvæsker eller blodlegemer resistente mod virusinfektion samt fremgangsmåde til fjernelse af vira

Country Status (7)

Country Link
EP (1) EP0213921B1 (da)
JP (1) JPH0717510B2 (da)
CN (1) CN1057231C (da)
CA (1) CA1326450C (da)
DE (1) DE3673288D1 (da)
DK (1) DK170139B1 (da)
IE (1) IE59277B1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH24467A (en) * 1987-03-03 1990-07-18 Hem Res Inc Synergistics interplay of lymphokines and dsrnas
AU728984B2 (en) * 1987-03-03 2001-01-25 Hem Research, Inc. Syngeristic interplay of lymphokines and dsRNAs
PH30882A (en) * 1987-03-03 1997-12-23 Hem Res Inc Activated Rnase L as a maker for viral infections.
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
ZA881639B (en) * 1987-03-23 1989-02-22 Hem Res Inc Treatment of human viral infection by dsrna combined with viral inhibitors
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
AU728894B2 (en) * 1987-07-17 2001-01-18 Hem Research, Inc. Double stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
IE66830B1 (en) * 1987-08-12 1996-02-07 Hem Res Inc Topically active compositions of double-stranded RNAs
US5683986A (en) * 1987-08-12 1997-11-04 Hemispherx Biopharma Inc. Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
PH25365A (en) * 1987-12-23 1991-05-13 Hem Research Rhase l inhibitor as a marker for virus infections
CA1320446C (en) * 1988-06-20 1993-07-20 William A. Carter Modulation of lymphokine-resistant cellular states by dsrnas
ES2066847T3 (es) * 1988-07-07 1995-03-16 Hem Pharma Corp Diagnostico y tratamiento del sindrome de fatiga cronica.
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
ATE147630T1 (de) * 1989-10-11 1997-02-15 Hem Pharma Corp Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
AR013269A1 (es) * 1997-08-04 2000-12-13 Scras Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
KR20010042069A (ko) 1998-03-20 2001-05-25 베니텍 오스트레일리아 리미티드 유전자 발현 조절방법
EP2314700A1 (en) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
AU2013206335B2 (en) * 2005-12-07 2017-05-04 Hemispherx Biopharma, Inc. dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
JP2009518410A (ja) * 2005-12-07 2009-05-07 へミスフェリックス・バイオファーマ インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのｄｓＲＮＡ
JP2024517181A (ja) 2021-04-28 2024-04-19 ウエヌイグレックオ・ファーマ 組合せ治療としてｆｘｒアゴニストを使用するｔｌｒ３アゴニストの効果の強い増強

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1412591A (en) * 1971-11-30 1975-11-05 Beecham Group Ltd Antiviral ds rna and compositions thereof
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells

Also Published As

Publication number Publication date
IE59277B1 (en) 1994-02-09
CN1057231C (zh) 2000-10-11
EP0213921B1 (en) 1990-08-08
JPS6277334A (ja) 1987-04-09
IE862276L (en) 1987-02-26
EP0213921A2 (en) 1987-03-11
JPH0717510B2 (ja) 1995-03-01
DE3673288D1 (de) 1990-09-13
CN86105436A (zh) 1987-09-16
EP0213921A3 (en) 1988-01-07
DK405286D0 (da) 1986-08-26
CA1326450C (en) 1994-01-25
DK170139B1 (da) 1995-06-06

Similar Documents

Publication Publication Date Title
DK405286A (da) Anvendelse af dobbeltstrenget rna til behandling af aids
DK38289A (da) Fremgangsmaade til selektiv haemning af hiv
DK376087D0 (da) Behandling af emulsioner
DK513988D0 (da) Fremgangsmaade til rensning af roeggas
DK238988D0 (da) Fremgangsmaade til fremstilling af 4-acyloxy-3-hydroxyethyl-azetidinoner
DK609885D0 (da) Fremgangsmaade til modifikation af organismer
DK363887A (da) Anvendelse af bromcruptin
DK653387A (da) Fremgangsmaade til dekomponering af acrylamid
DK119086A (da) Fremgangsmaade til fremstilling af oligonucleotider
DK263887D0 (da) Fremgangsmaade til behandling af affaldsprodukter
DK271588A (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK298187A (da) Applikator til behandling af laeber
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK78388D0 (da) Fremgangsmaade til fremstilling af 4-acetoxy-3-hydroxyethyl-azetidinon
DK299585D0 (da) Fremgangsmaade til behandling af syreholdige afgangsgasser
DK524588A (da) Middel til behandling af aids
DK453586A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid
DK625486A (da) Fremgangsmaade til rensning af roeggas
DK117487A (da) Fremgangsmaade til fremstilling af inulase
DK279488D0 (da) Fremgangsmaade til diagnosticering af aids
DK219885A (da) Tetrahydronaphthalenoler til behandling af hypertension
DK207487D0 (da) Fremgangsmaade til reduktion af elektrodeoploesning
DK510785A (da) Oploesning til behandling af taender
DK230586A (da) Oprensning af 5-pyrimidincarboxamider
DK625386A (da) Fremgangsmaade til behandling af instrumenter

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK